Experts say the emerging tech can dramatically accelerate advances in drug discovery, diagnostics and precision medicine.

Q4 2025 earnings call recap: 2026 revenue guidance, TearCare reimbursement milestone, OMNI growth outlook, margins and risks—read now.

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the life sciences tools & services stocks, including ...

Q4 2025 Management View CEO Mary Szela reported that "our results for both the fourth quarter and the full year were strong. Fourth quarter revenues were $13.2 million, and full year revenues were $45 ...

The Triangle’s life sciences sector is in the midst of one of the most significant growth waves in its history. But as the ...

Every life sciences company knows that patient safety is non negotiable, but the way safety is managed—and the value ...

Life sciences mergers and acquisitions surged back in force in 2025, as pharmaceutical and med-tech companies moved aggressively to shore up pipelines and offset looming revenue losses, according to ...

Caris Life Sciences Inc. CAI shares are up during Friday’s premarket session following better-than-expected fourth-quarter earnings and a significant interim readout from the company’s Achieve 1 study ...

Exact Sciences Corp. (NASDAQ:EXAS) is one of 15 stocks with the biggest hedge fund momentum, after gaining 31 hedge fund ...

MADISON (WKOW) -- Madison-based Exact Sciences is cutting about 4% of its overall workforce, impacting about 200 positions in Wisconsin. The company has 7,200 employees globally. An Exact Sciences ...

Every year, AIP awards physical scientists for their leadership and excellence. In recognition of women in the physical ...